Stacey Johnson
Stacey Johnson is the editor of Signals and a contributor. For 25 years, Stacey has been providing strategic communications counsel to government, corporate, technology and health organizations. She began her career at the CTV Television Network and then moved to Hill & Knowlton Canada where she advised clients in a variety of industries and sectors. Stacey is the Vice President, Communications and Marketing for CCRM, a leader in developing and commercializing regenerative medicine-based technologies and cell and gene therapies. She has a Master's degree in Public Relations. You can follow her on Twitter @msstaceyerin.
Posts by: Stacey
Right Turn: Good news for Canadian “butterfly boy”
Epidermolysis bullosa (EB) is a rare, and exceedingly painful, skin condition that I’ve written about here and here. Children with EB are sometimes referred to as “butterfly children” because their skin is said to be as fragile as a butterfly’s wings. The severity of the condition ranges from mild to fatal. Jonathan Pitre is a […]
A peek at exciting research happening at the University of Toronto
CCRM has been known to hire its graduates, consult with its esteemed professors, review disclosures from its faculty, collaborate on projects, and our Chief Scientific Officer, Dr. Peter Zandstra, is one of its respected professors. All of this to disclose that CCRM has very strong ties to the Institute of Biomedical Engineering (BME) at the […]
Right Turn: Synthetic biology predicted to become a huge industry
There is a trend in the regenerative medicine field to include gene therapies when describing the work being performed by academics and industry, as in “cell and gene therapies.” The wider definition better reflects how the industry is evolving and acknowledges the dual focus. I expect the same may happen with synthetic biology’s role in […]